Introduction
One of the major functions of the kidneys is to maintain the volume and composition of the body fluids constant despite wide variation in the daily intake of water and solutes. To accomplish this task, the activities of a number of transport proteins along the nephron are tightly regulated.
The nephron is the functional unit of the kidneys. Each human kidney contains approximately 1.2 millions of nephrons. At the beginning of each nephron, in the glomerulus, the blood is filtered: cells and most proteins are retained, whereas water and small solutes pass from the glomerular capillaries to the Bowman's capsule. As the glomerular filtrate leaves Bowman's capsule and enters the renal tubule, it flows sequentially through the proximal tubule, the loop of Henle, the distal tubule, and the collecting duct. Along this course, greater part of the glomerular filtrate is transported across and between the tubule cells and reenters the blood (reabsorption), whereas some is secreted from the blood into the luminal fluid (secretion). The formation of urine involves the sum of these three major processes: ultrafiltration of plasma by the glomerulus, reabsorption of water and solutes from the ultrafiltrate, and secretion of solutes into the tubular fluid. Although 180 liters of plasma is filtered by the human glomeruli each day, less than 1% of water, sodium chloride and variable amounts of other solutes are excreted in the urine. By the processes of reabsorption and secretion the renal tubule modulates the volume and composition of the urine. Consequently, the tubules precisely control the volume, composition, and pH of the body fluids.
The renal proximal tubule is responsible for reabsorption of the majority of the filtered sodium, bicarbonate, chloride and water. Na + /H + exchange is the predominant mechanism for absorption of Na + and secretion of H + across the apical membrane of proximal tubule cells (Alpern, 1990) . Apical membrane Na + /H + exchange also has a major role in mediating chloride reabsorption in the proximal tubule through its combined activity with a Cl -/base exchanger and by creating an increase in luminal chloride concentration that favors the diffusion of the anion from the tubular lumen to the blood (Warnock and Yee, 1981; Aronson and Giebisch, 1997) . The sodium/proton exchanger isoform 3 (NHE3) represents www.intechopen.com the major topic of this chapter; therefore the properties of the NHE family will be briefly discussed bellow. Fig. 1 . Schematic illustration of the nephron depicting the most important transport mechanisms involved with NaCl reabsorption in proximal tubule. The inset shows Na + /K + -ATPase, Na + /H + exchanger and Cl -/Base exchanger localization in proximal tubule. BL = basolateral; AP = apical. The mammalian Na + /H + exchanger (NHE) gene family (SLC9) consists of secondary active transporters that mediate the electroneutral exchange of intracellular protons for extracellular sodium (Aronson, 1985) . The transport activity of this protein is crucial to regulation of intracellular pH and cellular volume. In polarized epithelia, Na + /H + exchangers are also involved in transepithelial NaHCO3 and NaCl transport.
All members of the NHE family share a common structural feature. They consist of two major portions, an N-terminal transmembrane domain and a large cytoplasmic C-terminal domain. The N-terminal portion of all known isoforms is predicted to span the plasma membrane twelve times. This domain is responsible for the Na + /H + exchange transport function (Pouyssegur, 1994) . The C-terminal portion is mainly hydrophilic and it is the portion through which the activity of the exchanger is regulated.
Thus far, five sodium proton exchangers (NHE1, NHE2, NHE3, NHE4 and NHE8) have been identified in plasma membrane of renal tubular cells (Biemesderfer et al., 1992; Biemesderfer et al., 1993a; Amemiya et al., 1995; Chambrey et al., 1997; Chambrey et al., 1998) . Of these, NHE3, the most abundant NHE isoform in renal tissue, is confined to the apical membrane of proximal tubule and thin and thick ascending limb. Several lines of evidence strongly support the conclusion that NHE3 is the principal NHE isoform responsible for apical membrane Na + /H + exchange in the proximal tubule. First, studies Fig. 2 . Secondary structure of sodium/proton exchangers (NHE). All NHE isoforms have a membrane topology of 10-12 transmembrane segments. The carboxy-terminal region at the cytoplasmic site of NHE3 has consensus phosphorylation sites for PKA. using isoform-specific antibodies have demonstrated that NHE3 is expressed on the brush border membrane of proximal tubule cells (Biemesderfer et al., 1993b; Biemesderfer et al., 1997) . Second, the pattern of sensitivity to different inhibitors of Na + /H + exchange in renal brush border vesicles and of bicarbonate absorption in microperfused proximal tubules is most consistent with the properties of NHE3 among the known NHE isoforms (Vallon et al., 2000) . Third, micropuncture analysis on NHE3 knockout mice revealed a remarkable reduction of fluid and bicarbonate reabsorption in renal proximal tubule further supporting the concept that NHE3 is the isoform that accounts for most Na + /H + exchange in this nephron segment (Lorenz et al., 1999; Wang et al., 1999) . Indeed, mice lacking NHE3 display hypotension and had a mild hyperchloremic metabolic acidosis (Schultheis et al., 1998) . Despite the reduced salt reabsortive capacity in the renal proximal tubule, the NHE3 deficient mice grows well when fed a normal sodium diet, mostly due to reduced glomerular filtration rate and increased sodium and bicarbonate reabsorption in the distal nephron. However, if these animals are subjected to dietary salt restriction the adaptative mechanisms are not sufficient to fully compensate for the large defect on proximal reabsorption and they may die from hypovolemic shock (Ledoussal et al., 2001) .
Given the important role of NHE3 in mediating NaHCO 3 and NaCl reabsorption in the proximal tubule, this transporter is subject to acute and chronic regulation in response to a variety of conditions and humoral factors affecting acid-base or salt balance. In this chapter we will focus on the regulation of NHE3 by protein kinase A and the implications of this regulatory mechanism on renal function under physiological and pathophysiological conditions. The signal transduction cascade mediating the acute effect of NHE3 agonists and antagonists involves multiple pathways. One of the best studied regulatory mechanisms affecting NHE3 activity is the inhibition resulting from protein kinase A (PKA) activation. Hormones activating cAMP-dependent PKA have been shown to reduce sodium and bicarbonate reabsorption in renal proximal tubule by inhibiting NHE3 transport activity. Table 1 presents a summary of hormones and molecular mechanisms associated with inhibition of NHE3 by PKA. These hormones act via G-protein coupled receptors (GPCR) expressed in the apical membrane of the renal proximal tubule (Felder et al., 1984; Muff et al., 1992; Marks et al., 2003; Schlatter et al., 2007; Crajoinas et al., 2011) . GPCR signal transduction occurs through coupling to heterotrimeric G proteins on the intracellular side of the membrane. Heterotrimeric G proteins contain three subunits referred as Gα, G, and Gγ. Upon ligand binding, the GPCR undergoes a conformational change that promotes the exchange of bound guanosine diphosphate (GDP) from the Gα subunit for guanosine triphosphate (GTP). The G protein Gα subunit bound to GTP can then dissociate from the Gγ dimer and initiate the intracellular signaling cascade that leads to cAMP dependent PKA activation that further elicits NHE3 inhibition ( Fig. 3) . Fig. 3 . Downstream effect of a receptor coupled to adenylyl cyclase. The ligand (L) binds to its receptor coupled to protein G ( S ) and adenylyl cyclise (AC) is activated. The activated enzyme converts ATP to cAMP, which activates protein kinase A (PKA) which, in turn, is ready to phosphorylate NHE3 at the specific PKA consensus sites.
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Parathyroid hormone
The kidney is a principal target organ for the action of the parathyroid hormone (PTH). PTH is primarily involved in modulation of serum calcium and phosphate homeostasis but also acts on the proximal tubule, the thick ascending limb, and the distal convoluted tubule to alter urinary electrolyte and fluid excretion. The inhibitory effect of PTH on renal proximal Hormone/Condition Associated Mechanism References Parathyroid hormone  of NHE3 affinity for protons due to phosphorylation of the exchanger  of NHE3 maximum velocity due to a decrement of the number of NHE3 molecules at the plasma membrane  of NHE3 promoter activity, NHE3 mRNA and protein abundance Collazo et al., 2000; Zhang et al., 1999; Girardi et al., 2000; Bezerra et al., 2008) Dopamine  NHE3-mediated Na + /H + exchange due to increased endocytosis caused by increased PKA-mediated NHE3 phosphorylation (Gomes & Soares-da-Silva, 2004; Hu et al., 2001; Bacic et al., 2003) Glucagon-like peptide 1  NHE3 activity due to increased NHE3 phosphorylation (Crajoinas et al., 2011; Carraro-Lacroix et al., 2009 ) Glucagon Acutely - NHE via a PKAdependent pathway Chronically - NHE3 mRNA and protein expression at the plasma membrane (Amemiya et al., 2002) Guanylins  NHE3-mediated Na + /H + due to increased levels of NHE3 PKAdependent phosphorylation and reduction of the exchanger at the plasma membrane (Amorim et al., 2006 ; Lessa LM, Girardi AC, and Malnic G, unpublished observations)
High Salt Diet
Hypertension  NHE3-mediated Na + /H + due to higher NHE3 phosphorylation on serine 552, redistribution from microvilli to the intermicrovillar region together with its regulatory partner dipeptidyl peptidase IV  NHE3-mediated Na + /H + due to higher NHE3 phosphorylation on serine 552, redistribution of the transporter to the intermicrovillar region (Yang et al., 2008 ) (Magyar et al., 2000; Panico et al., 2009; Crajoinas et al., 2010) Heart Failure  NHE3-mediated sodium reabsorption due to increased renal cortical NHE3 mRNA and protein levels and lower levels of NHE3 phosphorylation at serine 552 (Lutken et al., 2009; Inoue et al., 2012) www.intechopen.com tubule NHE3 activity has been consistently reported by several laboratories on both in vivo (Bank and Aynediian, 1976; Girardi et al., 2000) and in vitro studies (Pollock et al., 1986; Mrkic et al., 1992; Mrkic et al., 1993) . Experiments performed in vitro and ex vivo provide evidence that the acute inhibition of NHE3 by PTH is mediated by molecular mechanisms the include reduction of the transporter's apparent affinity for protons in consequence of the direct phosphorylation of the exchanger followed by reduction of its maximum velocity due to a decrement of the number of NHE3 molecules expressed at the plasma membrane Collazo et al., 2000) . Consistent with a decrease of NHE3 surface expression in response to PTH, studies carried out by the McDonough laboratory have shown that reduction of NHE3 activity in response to acute treatment with this hormone is a consequence of NHE3 redistribution from the apical microvilli to the base of the intermicrovillar region of the proximal tubule brush border (Zhang et al., 1999) .
The chronic effect of PTH on NHE3 regulation has also been evaluated (Girardi et al., 2000; Bezerra et al., 2008) . Long term inhibition of NHE3 by PTH is associated with a reduction on NHE3 protein and mRNA levels. PTH also provokes a mild inhibitory effect on NHE3 promoter that seems to be PKA-dependent (Bezerra et al., 2008) .
Dopamine
The intrarenal dopamine natriuretic system is critical for mammalian sodium homeostasis. Numerous studies have demonstrated that dopamine remarkably increases urinary sodium excretion mainly by inhibiting tubular sodium reabsorption. The inhibitory effect of dopamine on NHE3 transport activity is mediated mainly via the dopamine D1 receptor and stimulation of adenylyl cyclase/PKA system and phospholipase C/PKC (Gomes and Soares-da-Silva, 2004) . The underlying molecular mechanisms by which dopamine decreases NHE3-mediated Na + /H + exchange in renal proximal tubule involves increased endocytosis and is associated with increased PKA-mediated NHE3 phosphorylation (Hu et al., 2001; Bacic et al., 2003) .
Glucagon-like peptide-1
Glucagon-like peptide-1 (GLP-1) is produced by posttranslational modification of the proglucagon gene product in the intestinal L-cells, predominantly localized in the colon and ileum (Holst, 1997; Drucker, 2005) . This incretin hormone plays an important role on the maintenance of systemic glucose homeostasis by stimulating insulin secretion and improving insulin sensitivity (Drucker, 2005) . Numerous reports in the literature have demonstrated that GLP-1 also exerts renoprotective actions. In this regard, continuous administration of GLP-1 induces diuresis and natriuresis in both humans (Gutzwiller et al., 2004; Gutzwiller et al., 2006) and experimental animal models (Moreno et al., 2002; Yu et al., 2003) .
The molecular mechanisms underlying the renal actions of GLP-1 seems to involve increases of GFR and RPF and decrease of NHE3-mediated Na + /H + exchange in the renal proximal tubule (Carraro-Lacroix et al., 2009 Crajoinas et al., 2011) . Increased NHE3 phosphorylation levels induced by GLP-1 was not accompanied by a decrease of NHE3 expression at the microvillar microdomain of the brush border, suggesting that the mechanism by which GLP-1 inhibits NHE3 activity does not involve subcellular redistribution of the exchanger between the subcompartiments of the renal proximal tubule brush border.
Glucagon
Glucagon is a 29-amino-acid pancreatic peptide produced by the α-cells present at the periphery of the islets of Langerhans (Baum et al., 1962) and its major function is the maintenance of plasma glucose homeostasis between meals and during fasting. Glucagon binding to its receptor primarily activates adenylyl cyclase and increases cAMP Rodbell et al., 1971) . The tissue distribution of the glucagon receptor is broad, with higher levels of expression in liver and kidney (Svoboda et al., 1993; Dunphy et al., 1998) .
In the kidney, glucagon affects renal glomerular filtration, renal blood flow, and decreases renal tubular sodium reabsorption (Pullman et al., 1967) . Part of the acute natriuretic action of glucagon are mediated by inhibition of NHE3 in the renal proximal tubule via a cAMP/PKAdependent pathway. Interestingly, in vitro studies using OKP cells have shown that glucagon acutely inihibits and chronically stimulates NHE3 activity (Amemiya et al., 2002) .
Guanylins
The guanylin and uroguanylin are endogenous ligants of the Escherichia coli heat-stable enterotoxin (STa) receptor, guanylate cyclase C (Currie et al., 1992; Fonteles et al., 1998) and are known to be involved in a control system that regulates salt balance in response to oral salt intake. Both guanylin and uroguanylin are synthesized in the intestine and in the kidney and have already been identified in several animal species, including as mammals, fishes and birds (Forte, 2004) .
The renal effects of uroguanylin are much more pronounced than the ones produced by guanylin and include natriuresis, kaliuresis, diuresis and increased excretion of cGMP (Forte et al., 1996; Greenberg et al., 1997; Fonteles et al., 1998) . In the renal proximal tubule, uroguanylin significantly inhibits NHE3 transport function (Amorim et al., 2006) . Ongoing studies by the Malnic laboratory have demonstrated that the mechanism by which uroguanyn inhibits NHE3 involves increased levels of NHE3 phosphorylation followed by retrieval of the exchanger from the plasma membrane (unpublished observations, Lessa LM, Girardi AC, and Malnic G) ). The mechanism by which NHE3 is phosphorylated by PKA in response to coupling of uroguanylin to its receptor in the renal proximal tubule possibly involves a crosstalk mechanism between cGMP and cAMP pathways.
The Na
+ /H + exchanger regulatory factor NHERF
Although a large number of hormones reported to affect NHE3 share the same signal pathways, the molecular mechanisms by which they regulate NHE3 may differ greatly among them. The identification of regulatory proteins that interact with NHE3 has unraveled some aspects of the molecular mechanisms underlying this transporter regulation.
The first NHE3 regulatory factor was isolated and characterized byWeinman and Shenolikar (Weinman et al., 1995; Weinman et al., 2000a; Weinman et al., 2000b) . These investigators
www.intechopen.com demonstrated that the presence of this cofactor was essential for PKA-mediated inhibition of NHE3. This protein was cloned and termed NHERF-1 (Na/H exchanger regulatory factor). Subsequently, in an attempt to identify proteins that interact with NHE3, Yun and coworkers used the C-terminus of NHE3 as a bait in a yeast two-hybrid screen and isolated E3KARP (exchanger-3 kinase A regulatory protein, or NHERF-2) . NHERF-1 and NHERF-2 are highly homologous proteins (52% sequence identity for the human orthologs) (Yun et al., 1997) . Physical association of NHERF-1 and NHERF-2 with NHE3 has been demonstrated by binding assays using fusion proteins or by co-precipitation experiments using transfected cells overexpressing NHE3.
NHERF-1 and NHERF-2 are both members of a family of proteins that contain two tandem PDZ domains (that are conserved modules that mediate protein-protein interaction) and a C-terminal ezrin-radixin-moesin (ERM) binding domain which anchors the proteins to the actin cytoskeleton through ezrin. Lamprecht and Yun have proposed a model whereby the complex NHERF/ezrin acts as a functional AKAP (A kinase anchoring protein) for NHE3, serving as a structural link between not only NHE3 and the cytoskeleton but also between NHE3 and PKA, since ezrin is capable of binding the RII regulatory subunit of PKA (Dransfield et al., 1997; Lamprecht et al., 1998) . The current model suggests that NHERF-1 is required for cAMP-dependent regulation of NHE3 and acts as an adapter to link NHE3 to ezrin, which then serves as a PKA anchoring protein. Upon activation of PKA by hormones and/or factors that increase intracellular cAMP, PKA phosphorylates serine residues in the C-terminal hydrophilic domain of NHE3 (Fig. 4) . Biochemical experiments with brush border vesicles isolated from NHERF-1 knockout mice corroborate with this model (Weinman et al., 2003) . These studies showed that NHERF-1 is crucial for PKA-mediated phosphorylation and inhibition of NHE3 transport activity. Moreover, NHE3 expression was not affected in these animals, showing that NHERF-1 plays an essential role on NHE3 modulation but it is not required for expression or apical targeting of the transporter in the proximal tubule (Weinman et al., 2003) . To date, four members of the NHERF family of PDZ domain proteins have been described. These proteins bind to a variety of membrane transporters regulating their cell surface expression, protein interactions as well as the formation of signaling complexes.
NHE3 phosphorylation at the PKA consensus sites
Moe and coworkers were the first to demonstrate that the cytoplasmic domain of NHE3 is a substrate for PKA in vitro . There are multiple putative consensus motifs for PKA on the NHE3 C-terminal region. Three of these sites (S552, S605 and S634) are highly conserved among species. Based on that, transfection studies using truncation of the NHE3 C-terminal domain and site direct mutagenesis of the above mentioned serine residues were carried out to evaluate whether PKA directly phosphorylates one or more of these consensus sites in vivo (Cabado et al., 1996; Kurashima et al., 1997; Zhao et al., 1999 ). Kurashima and coworkers have shown that both serines 605 and 634 are important for PKAmediated inhibition of NHE3, although only serine 605 is phosphorylated in vivo (Kurashima et al., 1997) . The studies by Zhao and colleagues confirmed that phosphorylation of serine 605 is increased by cAMP/PKA. These investigators also found that PKA directly phosphorylates serine 552 and that both 552 and 605 residues appear to be critical for inhibition of NHE3 by PKA (Zhao et al., 1999) .
Years later, the Aronson laboratory generated phosphospecific antibodies directed to the PKA consensus sites S552 and S605 of rat NHE3 (Kocinsky et al., 2005) . These reagents are of great value, since they have enable investigators to evaluate the phosphorylation state of these two residues in endogenous NHE3 under basal conditions, under a variety of physiological and pharmacological maneuvers and in disease states. Indeed, increments in the phosphorylation status of NHE3 at serines 552 and 605 have been shown to occur in response to dopamine (Kocinsky et al., 2005) , PTH (Kocinsky et al., 2007) , and GLP-1 (Crajoinas et al., 2011) .
Studies by Kocinsky and colleagues have also demonstrated that serine 552 is phosphorylated to a much greater extent than serine 605 in baseline in vivo. Moreover, these investigators found that when NHE3 is phosphorylated at serine 552, it mainly resides at the intermicrovillar domain of the brush border (Kocinsky et al., 2005) . This observation is consistent with a decrease on NHE3-mediated Na + /H + exchange in the renal proximal tubule, since within the intermicrovillar subcompartment of the brush border, this transporter must have very limited assess to the tubular fluid.
The precise mechanism by which NHE3 phosphorylation leads to NHE3 inhibition remains obscure. Although phosphorylation of NHE3 at the 552 and 605 residues are necessary for the PKA-dependent inhibitory effect, phosphorylation of NHE3 at these PKA consensus sites precedes transport inhibition (Kocinsky et al., 2007) indicating that phosphorylation per se is not sufficient to inhibit NHE3 activity. The current body of data suggests that PKA phosphorylation may ultimately result in inhibition of NHE3 by modulating NHE3 subcellular trafficking, interaction with regulatory proteins, or localization within the plasma membrane.
Pathophysiological Implications of NHE3 Phosphorylation by Protein Kinase A
As mentioned above, NHE3 is phosphorylated on serine 552 under basal conditions by the adenylyl cyclase/cAMP-activated-protein kinase A (PKA) and the endogenous levels of phosphorylation is often affected as part of acute NHE3 regulation. Interestingly, baseline levels of NHE3 phosphorylation at this residue may also be associated with chronic regulation of NHE3 activity.
High Salt Diet
During high salt diet the kidneys increase sodium and volume excretion to match intake. IYang and colleagues have demonstrated that three weeks of high salt diet (4%) doubled the levels of NHE3 phosphorylation at the serine 552 (Yang et al., 2008) , possibly contributing to the natriuretic effect triggered by high sodium load.
Hypertension
Mice lacking Na + /H + exchanger NHE3 are hypotensive and hypovolemic, underscoring the importance of the transporter on blood pressure control.
We have recently assessed in vivo NHE3 transport activity and defined the mechanisms underlying NHE3 regulation before and after development of hypertension in spontaneously hypertensive rats (SHR). By means of in vivo stationary microperfusion, we found that NHE3-mediated bicarbonate reabsorption is higher in the proximal tubule of 5-week-old pre-hypertensive spontaneously hypertensive rat (SHR) and lower in 14-week-old SHR compared to age-matched normotensive rats (Wistar Kyoto, WKY). Higher NHE3 activity in young pre-hypertensive SHR is associated with lower phosphorylation levels (serine 552) and increased NHE3 expression at the microvillar brush border. During the hypertensive stage, NHE3 was found to be mainly confined to the intermicrovillar region and the relative abundance of NHE3 phosphorylated on serine 552 is increased compared to normotensive animals ( Fig. 5) (Crajoinas et al., 2010) .
Heart failure
Heart failure (HF) is associated with sodium and water retention and extracellular volume expansion. A principal site of renal salt and water reabsorption is the proximal tubule. We therefore hypothesized that NHE3, the major apical transcellular pathway for sodium reabsorption in the proximal tubule, might be upregulated in heart failure. To test this hypothesis, we employed both stationary in vivo microperfusion and pH-dependent sodium uptake to verify whether NHE3 activity would be altered in the proximal tubule of an experimental model of heart failure (Antonio et al., 2009) . Our data demonstrated that heart failure rats display enhanced NHE3-mediated sodium reabsorption in the proximal tubule which may contribute to extracellular volume expansion and edema. In addition to increased renal cortical NHE3 expression at both protein and mRNA levels, we have also observed that the levels of NHE3 phosphorylation at serine 552 in renal cortical membranes of heart failure rats are lower than in Sham animals. Thus, the molecular mechanisms mediating enhanced sodium reabsorption in the renal proximal tubule of heart failure rats also involves posttranslational covalent modification of NHE3 (Fig. 5) (Inoue et al., 2012) .
Conclusion
PKA activation plays an important role in inhibiting the activity NHE3, the major apical transcellular pathway for sodium reabsorption in the proximal tubule. Similarly, PKA inhibition may be involved in NHE3 stimulation, as suggested by the studies carried out in young hypertensive and in heart failure animals. The elucidation of the mechanisms by which phosphorylation of NHE3 at the PKA consensus sites leads to inhibition of NHE3-mediated Na + /H + exchange in the renal proximal tubule may also unravel important molecular underpinnings that lead to the development and/or progression of primary kidney diseases and other conditions that affect the kidneys.
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Fig. 5. NHE3 activity negatively correlates with the levels of endogenous phosphorylation of the PKA consensus site, serine 552, located at the C-terminus region of the exchanger Adapted from (Crajoinas et al., 2010; Inoue et al., 2012) . ( 
